These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17005036)
21. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b. Wimmer J; Fujinaga K; Taube R; Cujec TP; Zhu Y; Peng J; Price DH; Peterlin BM Virology; 1999 Mar; 255(1):182-9. PubMed ID: 10049833 [TBL] [Abstract][Full Text] [Related]
22. Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. Gibbs JS; Regier DA; Desrosiers RC AIDS Res Hum Retroviruses; 1994 Apr; 10(4):343-50. PubMed ID: 8068414 [TBL] [Abstract][Full Text] [Related]
23. A doxycycline-dependent human immunodeficiency virus type 1 replicates in vivo without inducing CD4+ T-cell depletion. Legrand N; van der Velden GJ; Fang RHT; Douaisi M; Weijer K; Das AT; Blom B; Uittenbogaart CH; Berkhout B; Centlivre M J Gen Virol; 2012 Sep; 93(Pt 9):2017-2027. PubMed ID: 22647372 [TBL] [Abstract][Full Text] [Related]
24. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770 [TBL] [Abstract][Full Text] [Related]
25. Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted. Guan Y; Whitney JB; Detorio M; Wainberg MA J Virol; 2001 May; 75(9):4056-67. PubMed ID: 11287555 [TBL] [Abstract][Full Text] [Related]
26. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192 [TBL] [Abstract][Full Text] [Related]
27. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells. Chang LJ; Zhang C Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208 [TBL] [Abstract][Full Text] [Related]
28. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. Gibbs JS; Regier DA; Desrosiers RC AIDS Res Hum Retroviruses; 1994 Apr; 10(4):333-42. PubMed ID: 8068413 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies. Mukhtar M; Duan L; Bagasra O; Pomerantz RJ Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098 [TBL] [Abstract][Full Text] [Related]
30. Tat is required for efficient HIV-1 reverse transcription. Harrich D; Ulich C; García-Martínez LF; Gaynor RB EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells. Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713 [TBL] [Abstract][Full Text] [Related]
32. Limitation of Tat-associated transcriptional processivity in HIV-infected PBMC. Adams M; Wong C; Wang D; Romeo J Virology; 1999 May; 257(2):397-405. PubMed ID: 10329550 [TBL] [Abstract][Full Text] [Related]
33. The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication. Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A J Hum Virol; 2001; 4(1):8-15. PubMed ID: 11213934 [TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication. Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403 [TBL] [Abstract][Full Text] [Related]
35. Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells. Okamoto M; Chono H; Kawano Y; Saito N; Tsuda H; Inoue K; Kato I; Mineno J; Baba M Hum Gene Ther Methods; 2013 Apr; 24(2):94-103. PubMed ID: 23442049 [TBL] [Abstract][Full Text] [Related]
36. Tat-independent replication of human immunodeficiency viruses. Luznik L; Kraus G; Guatelli J; Richman D; Wong-Staal F J Clin Invest; 1995 Jan; 95(1):328-32. PubMed ID: 7814633 [TBL] [Abstract][Full Text] [Related]
37. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells. Zhu M; Duan L; Pomerantz RJ AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1093-101. PubMed ID: 8844014 [TBL] [Abstract][Full Text] [Related]
39. The genetic stability of a conditional live HIV-1 variant can be improved by mutations in the Tet-On regulatory system that restrain evolution. Zhou X; Vink M; Klaver B; Verhoef K; Marzio G; Das AT; Berkhout B J Biol Chem; 2006 Jun; 281(25):17084-17091. PubMed ID: 16627480 [TBL] [Abstract][Full Text] [Related]
40. Viral evolution as a tool to improve the tetracycline-regulated gene expression system. Das AT; Zhou X; Vink M; Klaver B; Verhoef K; Marzio G; Berkhout B J Biol Chem; 2004 Apr; 279(18):18776-82. PubMed ID: 14761948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]